Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is a safe and effective treatment for severe alopecia areata.

Mohs micrographic surgery is effective for treating basal cell carcinoma on the eyelid, while radiotherapy has higher recurrence rates, and topical vitamin D3 may reduce and delay BCC formation in mice.

The Megsin-Cre transgene is a new tool for genetic manipulation in the skin and upper digestive tract.

Compound 7p shows strong potential as an anticancer agent.

Baricitinib is effective and safe for treating alopecia areata.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Topical metformin may improve hair regrowth in CCCA when added to standard treatments.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Genosomes are promising for safe and effective gene delivery in therapy.

Disrupted citric acid metabolism stops hair growth.

Patients with non-small-cell lung cancer need significant survival gains to accept severe side effects.

A woman developed severe kidney injury from using simvastatin with ciclosporin, highlighting the need for careful monitoring when combining these drugs.

Surgical excision is the best treatment for SCC.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Herbomineral drugs effectively manage chemotherapy-induced diarrhea in oral cavity cancer patients.

The document's conclusion cannot be provided because the document is not readable or understandable.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Targeted cancer therapies often cause serious skin problems that need careful management.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

A new test more accurately detects citrulline in hair follicles and pilomatrixomas.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.